MMSI vs. CMD, NUVA, ATRC, SILK, COO, XRAY, HAE, NEOG, QDEL, and ICUI
Should you be buying Merit Medical Systems stock or one of its competitors? The main competitors of Merit Medical Systems include Cantel Medical (CMD), NuVasive (NUVA), AtriCure (ATRC), Silk Road Medical (SILK), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), Neogen (NEOG), QuidelOrtho (QDEL), and ICU Medical (ICUI). These companies are all part of the "medical" sector.
Merit Medical Systems (NASDAQ:MMSI) and Cantel Medical (NYSE:CMD) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.
Merit Medical Systems has a net margin of 7.94% compared to Cantel Medical's net margin of 4.72%. Merit Medical Systems' return on equity of 15.02% beat Cantel Medical's return on equity.
Merit Medical Systems received 201 more outperform votes than Cantel Medical when rated by MarketBeat users. Likewise, 68.90% of users gave Merit Medical Systems an outperform vote while only 65.53% of users gave Cantel Medical an outperform vote.
Merit Medical Systems has higher revenue and earnings than Cantel Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than Cantel Medical, indicating that it is currently the more affordable of the two stocks.
Merit Medical Systems has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Cantel Medical has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500.
In the previous week, Merit Medical Systems had 3 more articles in the media than Cantel Medical. MarketBeat recorded 3 mentions for Merit Medical Systems and 0 mentions for Cantel Medical. Merit Medical Systems' average media sentiment score of 1.61 beat Cantel Medical's score of 0.00 indicating that Merit Medical Systems is being referred to more favorably in the media.
99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 84.1% of Cantel Medical shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 10.7% of Cantel Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Merit Medical Systems presently has a consensus price target of $92.78, suggesting a potential upside of 12.62%. Given Merit Medical Systems' higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than Cantel Medical.
Summary
Merit Medical Systems beats Cantel Medical on 14 of the 17 factors compared between the two stocks.
Get Merit Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Merit Medical Systems Competitors List
Related Companies and Tools